Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity
Clinical trial NCT00393783 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00393783
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.